We are live on ! Find out more
ARAY icon

Accuray

2.12 USD
-0.38
15.2%
At close Updated Nov 19, 4:00 PM EST
Pre-market
After hours
2.10
-0.02
0.94%
1 day
-15.2%
5 days
-31.17%
1 month
-62.94%
3 months
-82.02%
6 months
-81.45%
Year to date
-93.76%
1 year
-94.27%
5 years
-99.02%
10 years
-99%
 

About: Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention. The company has one operating segment which develops, manufactures and markets proprietary medical devices used in radiation therapy for the treatment of cancer patients.

Employees: 809

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 0%
Neutral 100%
Negative 0%
Neutral
PRNewsWire
6 days ago
Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
MADISON, Wis., Nov. 13, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it has completed its financing transaction with TCW Asset Management Company LLC ("TCW"), the company's primary lender and largest shareholder.
Accuray Closes TCW Transaction, Strengthening Balance Sheet to Support Long-Term Value Growth
Neutral
Seeking Alpha
14 days ago
Accuray Incorporated (ARAY) Q1 2027 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2027 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2027 Earnings Call Transcript
Neutral
PRNewsWire
15 days ago
Accuray Announces 1-for-40 Reverse Stock Split
MADISON, Wis., Nov. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that its Board of Directors has approved a 1-for-40 reverse stock split of the Company's common stock and a corresponding decrease to the authorized number of shares of common stock.
Accuray Announces 1-for-40 Reverse Stock Split
Neutral
PRNewsWire
15 days ago
Accuray Reports Fiscal 2027 First Quarter Financial Results
MADISON, Wis., Nov. 4, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the first quarter ended September 30, 2026.
Accuray Reports Fiscal 2027 First Quarter Financial Results
Neutral
PRNewsWire
20 days ago
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., Oct. 30, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Sofiane Laoussadi, the company's new Senior Vice President, Global Services & Solutions.
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
Neutral
PRNewsWire
29 days ago
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
MADISON, Wis., Oct. 21, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2027, ended September 30, 2026, during a conference call hosted by company management at 1:30 p.m.
Accuray to Report First Quarter Fiscal 2027 Financial Results on November 4, 2026
Neutral
PRNewsWire
1 month ago
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
MADISON, Wis., Oct. 6, 2026 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) today announced that stockholders approved all proposals presented at the company's Special Meeting of Stockholders held on October 6, 2026, enabling Accuray to complete its previously announced transactions with TCW Asset Management Company LLC, the company's primary lender and largest shareholder.
Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent Director
Neutral
PRNewsWire
1 month ago
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
MADISON, Wis., Sept. 27, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogica") to pursue advanced volumetric imaging capabilities for the CyberKnife® System.
Accuray and Samsung NeuroLogica Advance Volumetric Imaging Collaboration for the Accuray CyberKnife® Platform
Neutral
PRNewsWire
2 months ago
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
MADISON, Wis., Sept. 11, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY), a leading provider of radiation therapy systems for cancer treatment, and RaySearch Laboratories AB (publ) today announced that they had entered into a definitive agreement providing for an expanded collaboration aimed at accelerating Accuray's adoption of online adaptive radiation therapy.
Accuray and RaySearch Agree to Collaboration Integrating RayStation Software with Accuray Platforms to Accelerate Accuray's Online Adaptive Capabilities
Neutral
Seeking Alpha
3 months ago
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Accuray Incorporated (ARAY) Q4 2026 Earnings Call Transcript
Price charts implemented using Lightweight Charts™